QR Code

Short-term efficacy and safety of biologics and Janus kinase inhibitors for patients with atopic dermatitis: A systematic review and meta-analysis

Background: In recent years, biologics targeting key cytokines and Janus kinase (JAK) inhibitors have demonstrated favorable efficacy and safety outcomes for atopic dermatitis (AD) therapy. To evaluate the short-term efficacy and safety of AD therapy involving biologics, JAK inhibitors, and their co...

Full description

Saved in:
Main Authors: Qianyu Chen, Lian Cui, Yifan Hu, Zeyu Chen, Yunlu Gao, Yuling Shi
Format: Artigo
Language:Inglês
Published: Elsevier 2023-11-01
Series:Heliyon
Subjects:
Atopic dermatitis
Biologics
Janus kinase inhibitors
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023092228
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items